Page last updated: 2024-11-08

dibenzylfluorescein

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

dibenzylfluorescein: a fluorescent probe; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID371436
CHEMBL ID1987290
SCHEMBL ID1104941
MeSH IDM0558248

Synonyms (20)

Synonym
NCI60_015634
nsc-645658
o-benzylfluorescein benzyl ester
benzyl 2-(3-benzyloxy-6-oxo-xanthen-9-yl)benzoate
nsc645658
benzyl 2-(3-oxo-6-phenylmethoxyxanthen-9-yl)benzoate
dibenzylfluorescein
SCHEMBL1104941
CHEMBL1987290
benzyl 2-[6-(benzyloxy)-3-oxo-3h-xanthen-9-yl]benzoate #
3(3h)-xanthenone, 6-benzyloxy-9-[2-(benzyloxycarbonyl)phenyl]-
us9173935, dbf
bdbm189325
97744-44-0
dibenzylflorescein
mfcd13184323
benzyl 2-(6-(benzyloxy)-3-oxo-3h-xanthen-9-yl)benzoate
benzyl2-(6-(benzyloxy)-3-oxo-3h-xanthen-9-yl)benzoate
CS-0066705
HY-116862
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.18

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.18 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index5.12 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.18)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]